Prolonged survival of microencapsulated neonatal porcine islets in mice treated with a combination of anti-CD154 and anti-LFA-1 monoclonal antibodies

被引:22
|
作者
Kobayashi, T
Harb, G
Rayat, GR
机构
[1] Univ Alberta, Surg Med Res Inst, Dept Surg, Edmonton, AB T6G 2N8, Canada
[2] Nara Med Univ, Dept Surg 1, Kashihara, Nara 634, Japan
关键词
neonatal porcine islets; microencapsulation; CD154; LFA-1; monoclonal antibodies;
D O I
10.1097/01.TP.0000173773.01811.88
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background. The aim of this study was to determine whether short-term administration of a combination of anti-CD154 and anti-LFA-I monoclonal antibodies can prolong the survival of microencapsulated neonatal porcine islets (NPI) in immunocompetent mice. Methods. Microencapsulated NPI were transplanted into the peritoneal cavity of streptozotocin-induced diabetic B6 mice that received a short-term treatment of a combination of anti-CD154 and anti-LFA-1 monoclonal antibodies. Blood glucose levels of each recipient were measured for more than 100 days posttransplantation or until graft rejection. Microcapsules were recovered to determine the presence of immune cells using immunoperoxidase staining. In addition, the levels of mouse anti-porcine immunoglobulin (Ig) G antibodies in the serum of each recipient were measured by flow cytometry. Results. Short-term administration of a combination of monoclonal antibodies resulted in significant prolongation of microencapsulated NPI xenograft survival. All treated mice (n=20) achieved normoglycemia within 10-35 days posttransplantation and 11/20 mice remained normoglycemic for more than 100 days posttransplantation. In contrast, only 1/20 of the untreated mice achieved normoglycemia and this mouse became diabetic at 17 days posttransplantation. Histological examination of the recovered microcapsules from long-term surviving treated mice revealed minimal cellular overgrowth containing intact viable islets, whereas several layers of immune cells surrounding the capsules containing nonviable islets were observed in untreated mice. The levels of mouse anti-porcine IgG was also reduced in treated recipients compared to untreated mice. Conclusions. These data demonstrate that short-term administration of anti-CD154 and anti-LFA-1 monoclonal antibodies can be effective in promoting long-term survival of microencapsulated NPI in immune-competent mice.
引用
收藏
页码:821 / 827
页数:7
相关论文
共 50 条
  • [21] Variation in the ordered structure of complexes between CD154 and anti-CD154 monoclonal antibodies
    Ferrant, JL
    Wilson, CA
    Benjamin, CD
    Hess, DM
    Hsu, YM
    Karpusas, M
    Roux, KH
    Taylor, FR
    MOLECULAR IMMUNOLOGY, 2002, 39 (1-2) : 77 - 84
  • [22] PREVENTION OF AUTOIMMUNE IDDM IN NOD MICE BY ANTI-LFA-1 AND ANTI-ICAM-1 MONOCLONAL-ANTIBODIES
    AMANO, K
    TAKI, T
    HASEGAWA, Y
    MORIYAMA, Y
    TSUKAMOTO, K
    MIKI, M
    YONEDA, Y
    TOMINAGA, Y
    YAGI, N
    YOKONO, K
    KASUGA, M
    DIABETOLOGIA, 1993, 36 : A10 - A10
  • [23] UVB irradiation with anti-CD154 antibody prolonged the survival of hair follicle allografts in humanized mice
    Kim, J.
    Yoon, J.
    Kang, B.
    Park, H.
    Wi, H.
    Jung, K.
    Jo, S.
    Kim, K.
    Kwon, O.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2016, 136 (05) : S122 - S122
  • [24] Effect of anti-ICAM-1 and anti-LFA-1 monoclonal antibodies in experimental islet transplantation
    Arai, K
    Sunamura, M
    Amikura, K
    Kobari, M
    Matsuno, S
    GASTROENTEROLOGY, 1997, 112 (04) : A1428 - A1428
  • [25] Prolongation of corneal xenograft survival with deoxyspergualin and anti-LFA-1 monoclonal antibody
    Yamagami, S
    Isobe, M
    Yamagami, H
    Hori, J
    Kaburaki, T
    Tsuru, T
    TRANSPLANTATION PROCEEDINGS, 1997, 29 (04) : 2288 - 2289
  • [26] PREVENTION OF AUTOIMMUNE DIABETES BY TREATMENT WITH ANTI-LFA-1 AND ANTI-ICAM-1 MONOCLONAL-ANTIBODIES
    HEROLD, KC
    VEZYS, V
    GAGE, A
    MONTAG, A
    CLINICAL RESEARCH, 1994, 42 (02): : A119 - A119
  • [27] PREVENTION OF AUTOIMMUNE DIABETES BY TREATMENT WITH ANTI-LFA-1 AND ANTI-ICAM-1 MONOCLONAL-ANTIBODIES
    HEROLD, KC
    VEZYS, V
    GAGE, A
    MONTAG, AG
    CELLULAR IMMUNOLOGY, 1994, 157 (02) : 489 - 500
  • [28] Assessment of tolerance induction to cardiac allograft by anti-ICAM-1 and anti-LFA-1 monoclonal antibodies
    Isobe, M
    Suzuki, JI
    Yamazaki, S
    Horie, S
    Okubo, Y
    Sekiguchi, M
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 1997, 16 (11): : 1149 - 1156
  • [29] ANTI-LFA-1 (CD11A) MONOCLONAL-ANTIBODY INTERFERES WITH NEONATAL INDUCTION OF TOLERANCE TO ALLOANTIGENS
    SCHURMANS, S
    GONZALEZ, A
    REVILLA, C
    RAMOS, A
    LAMBERT, PH
    MERINO, J
    EUROPEAN JOURNAL OF IMMUNOLOGY, 1994, 24 (04) : 985 - 990
  • [30] TMA Development in Kidney and Heart Xenografts Treated with Anti-CD40 or Anti-CD154 Antibodies.
    Ma, D. H.
    Sasaki, H.
    Ahrens, K.
    Becerra, D.
    Rickert, C. G.
    Detelich, D. M.
    Oura, T.
    Somer, W.
    Rosales, I.
    Pierson, R. N.
    Markmann, J.
    Madsen, J. C.
    Kuwai, T.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2019, 19 : 1054 - 1054